🔎 Trials Near Me

Akèy › Myelom Miltip › New York › Rochester

Etid klinik pou Myelom Miltip nan Rochester, NY

8 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

Ap rekriteFaz 2
  • University of Rochester Medical Center, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06500884

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 2
  • University of Rochester Medical Center, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04634552

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Ap rekriteFaz 3
  • University of Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04566328

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Ap rekriteFaz 3
  • University of Rochester, Rochester
Tout laj · Tout sèks · Mizajou Jun 10, 2026 · NCT05561387

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

Ap rekriteFaz 1
  • University of Rochester Medical Center, Rochester
Laj 18 ak plis · Tout sèks · Mizajou May 19, 2026 · NCT06433947

Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

Ap rekriteFaz 2
  • Wilmot Cancer Center, Clinical Trial Office of the University of Rochester Medical Center, Rochester
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT06993675

Umbilical Cord Blood Transplantation From Unrelated Donors

Ap rekriteEtid obsèvasyon
  • Wilmot Cancer Institute, Rochester
2 Months – 75 Years · Tout sèks · Mizajou Oct 10, 2025 · NCT03016806

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

Ap rekriteFaz 2
  • University of Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Feb 10, 2025 · NCT05597345

Etid Myelom Miltip nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.